Overview

BHV-4157 in Adult Subjects With Obsessive Compulsive Disorder

Status:
Active, not recruiting
Trial end date:
2022-06-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of BHV-4157 versus placebo in subjects with Obsessive Compulsive Disorder (OCD).
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Biohaven Pharmaceutical Holding Company Ltd.
Biohaven Pharmaceuticals, Inc.